Sangamo Therapeutics (SGMOQ) EBITDA Margin (2010 - 2025)
Sangamo Therapeutics' EBITDA Margin came in at -261.49% for Q4 2025, up 66.27 percentage points from -327.76% a year earlier and up 5687.56 percentage points from the prior quarter.
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) EBITDA Margin (2010 - 2025) Analysis & Trends
For FY2025, Sangamo Therapeutics' EBITDA Margin was -296.42%, down 125.38 percentage points from FY2024.
- EBITDA Margin carries a five-year change of -191.63 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was -171.04% in FY2024 (-24.13 pp), -146.91% in FY2023 (+23.06 pp), -169.97% in FY2022 (-12.88 pp) and -157.09% in FY2021 (-52.30 pp).
- The five-year range for quarterly EBITDA Margin is -10419.96% (Q1 2024) to 23.98% (Q3 2024).
- Year-over-year, EBITDA Margin increased in five of the last eight quarters, with an average year-over-year change of -124.16 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in Q2 2025 (a gain of 9975.87 percentage points), and the weakest in Q1 2024 (a drop of 10433.58 percentage points).
- Business Quant data shows SGMOQ's EBITDA Margin at -5949.05% (Q3 2025), -92.11% (Q2 2025) and -444.43% (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Sangamo Therapeutics | 39.23 Mn | -74.88 Mn | - | -261.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -261.49% |
| Sep 30, 2025 | -5,949.05% |
| Jun 30, 2025 | -92.11% |
| Mar 31, 2025 | -444.43% |
| Dec 31, 2024 | -327.76% |
| Sep 30, 2024 | 23.98% |
| Jun 30, 2024 | -10,067.98% |
| Mar 31, 2024 | -10,419.96% |
| Dec 31, 2023 | -2,947.94% |
| Sep 30, 2023 | -1,073.79% |
| Jun 30, 2023 | -1,745.66% |
| Mar 31, 2023 | 13.63% |
| Dec 31, 2022 | -191.15% |
| Sep 30, 2022 | -195.94% |
| Jun 30, 2022 | -145.86% |
| Mar 31, 2022 | -150.29% |
| Dec 31, 2021 | -132.69% |
| Sep 30, 2021 | -160.63% |
| Jun 30, 2021 | -166.67% |
| Mar 31, 2021 | -169.05% |
API Access
Sangamo Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SGMOQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "SGMOQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();